DPYSL5 and paraneoplastic neurologic syndrome: A few studies showed that OCB are directed against CV2/CRMP5, amphiphysin, HuD, Yo [12–14] and Ri [15] in patients suffering from paraneoplastic neurological syndromes as well as in infectious diseases against the Human Immunodeficiency Virus (HIV) [16] and borrelia [17].